Human Recombinant OLFM4 protein, His Tag (V2LY-0526-LY5869)

Go to compare Compare Online Inquiry
Request for COA
Datasheet Target References Q & As Review & reward Protocols Associated Products

Basic Information

Expressed Host
HEK293 Cells
Protein Species
Human
Tag
His Tag
Protein Construction
This product is Human Recombinant OLFM4 protein, His Tag consist of Amino Acid: 1-510 and predicts a molecular mass of 56.6 kDa.
Molecule Mass
56.6 kDa
Sequence
Amino Acid: 1-510
Species
Human

Formulations & Storage [For reference only, actual COA shall prevail!]

Purity
>92% as determined by SDS-PAGE
Endotoxin
Please contact us for more information.
Format
Lyophilized
Reconstitution
Allow the vial and reconstitution buffer to equilibrate to room temperature. Briefly centrifuge or tap down the vial to ensure that all lyophilized powder is collected at the bottom of the vial. For the reconstitution of this product, we recommend adding PBS or sterile water to achieve a final antibody concentration of 1 mg/mL. Allow the vial to reconstitute for 10-15 minutes at room temperature with gentle agitation. Avoid vigorous shaking that can cause foaming and antibody denaturation. Aliquot into volumes based on your experiment and store liquid protein at -20°C or -80°C for long time.
Buffer
Lyophilized from sterile PBS
Preservative
None
Storage
Samples are stable for up to twelve months from date of receipt at -20°C to -80°C. Store it under sterile conditions at -20°C to -80°C. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
More Infomation

Target

Full Name
Olfactomedin 4
Function
May promote proliferation of pancreatic cancer cells by favoring the transition from the S to G2/M phase. In myeloid leukemic cell lines, inhibits cell growth and induces cell differentiation and apoptosis. May play a role in the inhibition of EIF4EBP1 phosphorylation/deactivation. Facilitates cell adhesion, most probably through interaction with cell surface lectins and cadherin.
Biological Process
Cell adhesionIEA:UniProtKB-KW
Positive regulation of substrate adhesion-dependent cell spreadingManual Assertion Based On ExperimentIDA:UniProtKB
Signal transductionManual Assertion Based On ExperimentIBA:GO_Central
Cellular Location
Secreted, extracellular space
Mitochondrion
Subcellular location is not clearly defined: has been shown to be secreted (PubMed:16566923), but also in the mitochondrion (PubMed:15059901 and PubMed:20724538), cytoplasm and plasma membrane (PubMed:20724538) and in the nucleus (PubMed:15059901).
PTM
N-glycosylated.

Xu, K., Zheng, P., Zhao, S., Wang, J., Feng, J., Ren, Y., ... & Xie, P. (2023). LRFN5 and OLFM4 as novel potential biomarkers for major depressive disorder: a pilot study. Translational Psychiatry, 13(1), 188.

Liu, W., Li, H., Aerbajinai, W., Botos, I., & Rodgers, G. P. (2022). OLFM4-RET fusion is an oncogenic driver in small intestine adenocarcinoma. Oncogene, 41(1), 72-82.

Ren, X., Geng, M., Xu, K., Lu, C., Cheng, Y., Kong, L., ... & Xu, P. (2021). Quantitative proteomic analysis of synovial tissue reveals that upregulated OLFM4 aggravates inflammation in rheumatoid arthritis. Journal of proteome research, 20(10), 4746-4757.

Gong, F., Li, R., Zheng, X., Chen, W., Zheng, Y., Yang, Z., ... & Chen, E. (2021). OLFM4 regulates lung epithelial cell function in sepsis-associated ARDS/ALI via LDHA-mediated NF-κB signaling. Journal of inflammation research, 7035-7051.

Gao, X. Z., Wang, G. N., Zhao, W. G., Han, J., Diao, C. Y., Wang, X. H., ... & Li, W. C. (2019). Blocking OLFM4/HIF‐1α axis alleviates hypoxia‐induced invasion, epithelial–mesenchymal transition, and chemotherapy resistance in non‐small‐cell lung cancer. Journal of Cellular Physiology, 234(9), 15035-15043.

Valo, I., Raro, P., Boissard, A., Maarouf, A., Jézéquel, P., Verriele, V., ... & Guette, C. (2019). OLFM4 Expression in Ductal Carcinoma In Situ and in Invasive Breast Cancer Cohorts by a SWATH‐Based Proteomic Approach. Proteomics, 19(21-22), 1800446.

Fu, J., Dong, G., Shi, H., Zhang, J., Ning, Z., Bao, X., ... & Xiong, B. (2019). LncRNA MIR503HG inhibits cell migration and invasion via miR‐103/OLFM4 axis in triple negative breast cancer. Journal of cellular and molecular medicine, 23(7), 4738-4745.

Ashizawa, Y., Kuboki, S., Nojima, H., Yoshitomi, H., Furukawa, K., Takayashiki, T., ... & Ohtsuka, M. (2019). OLFM4 enhances STAT3 activation and promotes tumor progression by inhibiting GRIM19 expression in human hepatocellular carcinoma. Hepatology Communications, 3(7), 954-970.

Li, J., Liu, C., Li, D., Wan, M., Zhang, H., Zheng, X., ... & Sun, Q. (2019). OLFM4 inhibits epithelial–mesenchymal transition and metastatic potential of cervical cancer cells. Oncology Research, 27(7), 763.

Ask a question We look forward to hearing from you.
0 reviews or Q&As
Loading...
Have you used Human Recombinant OLFM4 protein, His Tag?
Submit a review and get a Coupon or an Amazon gift card. 20% off Coupon $30 eGift Card
Submit a review
Loading...
For research use only. Not intended for any clinical use.

Custom Antibody Labeling

We also offer labeled antibodies developed using our catalog antibody products and nonfluorescent conjugates (HRP, AP, Biotin, etc.) or fluorescent conjugates (Alexa Fluor, FITC, TRITC, Rhodamine, Texas Red, R-PE, APC, Qdot Probes, Pacific Dyes, etc.).

Online Inquiry

Contact us

  • Tel: (USA)
  • (UK)
  • Fax:
  • Email:

Submit A Review

online inquiry
Online Inquiry

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.